Mechanism of thrombin clearance by human astrocytoma cells

Journal of Neurochemistry

Volumn 72, Issue 3, 1999, Pages 980-987

  Mentz, Stefani ^a   De Lacalle, Sonsoles ^a   Baerga Ortiz, Abel ^b   Knauer, Mary F ^c   Knauer, Daniel J ^c   Komives, Elizabeth A ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Astrocytes; Low density lipoprotein receptor related protein; Protease nexin 1; Receptor associated protein; Thrombin

Indexed keywords

BINDING PROTEIN; HEPARIN; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEASE NEXIN I; THROMBIN;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTOMA CELL; CLEARANCE; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION;

AMYLOID BETA-PROTEIN PRECURSOR; ASTROCYTOMA; BRAIN NEOPLASMS; CARRIER PROTEINS; EPIDERMAL GROWTH FACTOR; HEPARIN; HUMANS; NEOPLASM PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, LDL; THROMBIN; THROMBOMODULIN; TUMOR CELLS, CULTURED;

EID: 0033009193     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0720980.x     Document Type: Article

References (43)

1. Akiyama H., Skeda K., Kondo H., and McGeer P. L. (1992) Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci. Lett. 146, 152-154.
2. Baker J. B., Low D. A., Sommer R. L., and Cunningham D. D. (1980) Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 21, 37-45.
3. Baker J. B., Knauer D., and Cunningham D. D. (1986) The Receptors, Vol. 3 (Conn P. M., ed), pp. 153-172. Academic Press, New York.
4. Barna B. P., Chou S. M., Jacobs B., Raushoff R. M., Hahn J. F., and Bay J. W. (1985) Enhanced DNA synthesis of human glial cells exposed to human leukocyte products. J. Neuroimmunol. 10, 151-158.
5. Choi B. H., Kim R. C., Vaughan P. J., Lau A., Van Nostrand W. E., Cotman C. W., and Cunningham D. D. (1995) Decreases in protease nexins in Alzheimer's disease. Neurobiol. Aging 16, 557-562.
6. Clatworthy A. E., Gomez-Isla T., Rebeck G. W., Wallace R. B., and Hyman B. T. (1997) Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease. Arch. Neurol. 54, 1289-1292.
7. 2-macroglobulin receptor. J. Biol. Chem. 269, 17886-17892.
8. Conway E. M., Pollefeyt S., Collen D., and Steiner-Mosonyi M. (1997) The amino terminal lectin-like domain of thrombomodulin is required for constitutive endocytosis. Blood 89, 652-661.
9. Cunningham D. D. (1992) Regulation of neuronal cells and astrocytes by protease nexin-1 and thrombin. Ann. NY Acad. Sci. 674, 228-236.
10. Cunningham D. D., Pulliam L., and Vaughan P. J. (1993) Protease nexin-1 and thrombin: injury-related processes in the brain. Thromb. Haemost. 70, 168-171.
11. Fallin D., Kundtz A., Town T., Gauntlett A. C., Duara R., Barker W., Crawford F., and Mullan M. (1997) No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample. Neurosci. Lett. 233, 145-147.
12. Festoff B. W., Rao J. S., Rayford A., and Hantai D. (1991) Plasminogen activators and inhibitors in the neuromuscular system. III. The serpin protease nexin I is synthesized by muscle and localized at neuromuscular synapses. J. Cell. Physiol. 147, 76-86.
13. 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Ann. NY Acad. Sci. 737, 20-38.
14. Herz J., Goldstein J. L., Strickland D. K., Ho Y. K., and Brown M. S. (1991) 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J. Biol. Chem. 266, 21232-21238.
15. Houenou L. J., Turner P. L., Li L., Oppenheim R. W., and Festoff B. W. (1995) A serine protease inhibitor, protease nexin-1, rescues motoneurons from naturally occurring and axotomy-induced cell death. Proc. Natl. Acad. Sci. USA 92, 895-899.
16. Howard E. W. and Knauer D. J. (1986) Human protease nexin-I. J. Biol. Chem. 261, 684-689.
17. Howard E. W. and Knauer D. J. (1987) Characterization of the receptor for protease nexin-I:protease complexes on human fibroblasts. J. Cell. Physiol. 131, 276-283.
18. Kalaria R. N. and Grahovac I. (1990) Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease. Brain Res. 516, 349-353.
19. Kamboh M. I., Aston C. E., and Dekosky S. T. (1998) Association between ACT polymorphism and Alzheimer's disease. Neurology 50, 574-576.
20. Kang D. E., Saitoh T., Chen X., Xia Y., Masliah E., Hansen L. A., Thomas R. G., Thal L. J., and Katzman R. (1997) Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 49, 56-61.
21. Knauer M. F., Kridel S. J., Hawley S. B., and Knauer D. J. (1997a) The efficient catabolism of thrombin-protease nexin 1 complexes is a synergistic mechanism that requires both the LDL receptor-related protein and cell surface heparins. J. Biol. Chem. 272, 29039-29045.
22. Knauer M. F., Hawley S. B., and Knauer D. J. (1997b) Identification of a binding site in protease nexin I (PN1) required for the receptor mediated internalization of PN1-thrombin complexes. J. Biol. Chem. 272, 12261-12264.
23. Lendon C. L., Talbot C. J., Craddock N. J., Han S. W., Wragg M., Morris J. C., and Goate A. M. (1997) Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci. Lett. 222, 187-190.
24. Liu Y., Fields R. D., Festoff B. W., and Nelson P. G. (1994) Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction. Proc. Natl. Acad. Sci. USA 91, 10300-10304.
25. Monard D., Niday E., Limat A., and Solomon F. (1983) Inhibition of protease activity can lead to neurite extension in neuroblastoma cells. Prog. Brain Res. 58, 359-364.
26. Monard D., Suidan H. S., and Nitsch C. (1992) Relevance of the balance between glia-derived nexin and thrombin following lesion in the nervous system. Ann. NY Acad. Sci. 674, 237-242.
27. Parekh R. B., Tse A. G., Dwek R. A., Williams A. F., and Rademacher T. W. (1987) Tissue-specific N-glycosylation, site-specific oligosaccharide patterns and lentil lectin recognition of rat Thy-1. EMBO J. 6, 1233-1244.
28. Pike C. J., Vaughan P. J., Cunningham D. D., and Cotman C. W. (1996) Thrombin attenuates neuronal cell death and modulates astrocyte reactivity induced by β-amyloid in vitro. J. Neurochem. 66, 1374-1382.
29. Pindon A., Hantai D., Jandrot-Perrus M., and Festoff B. W. (1997) Novel expression and localization of active thrombomodulin on the surface of mouse brain astrocytes. Glia 19, 259-268.
30. 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 37, 211-217.
31. Rosenblatt D. E., Cotman C. W., Nieto-Sampedro M., Rowe J. W., and Knauer D. J. (1987) Identification of a protease inhibitor produced by astrocytes that is structurally and functionally homologous to human protease nexin-I. Brain Res. 415, 40-48.
32. Rosenblatt D. E., Geula C., and Mesulam M. M. (1989) Protease nexin I immunostaining in Alzheimer's disease. Ann. Neurol. 26, 628-634.
33. Smith-Swintosky V. L., Zimmer S., Fenton J. W. II, and Mattson M. P. (1995) Opposing actions of thrombin and protease nexin-1 on amyloid β-peptide toxicity and an accumulation of peroxides and calcium in hippocampal neurons. J. Neurochem. 65, 1415-1418.
34. Sommer J., Gloor S. M., Rovelli G. F., Hofteenge J., Nick H., Meier R., and Monard D. (1987) cDNA sequence coding for a rat glial-derived nexin and its homology to members of the serpin superfamily. Biochemistry 26, 6407-6410.
35. Stone S. R., Brown-Leudi M. L., Rovelli G., Guidolin A., McGlynn E., and Monard D. (1994) Localization of the heparin-binding site of glial-derived nexin/protease nexin-1 by site directed mutagenesis. Biochemistry 33, 7731-7735.
36. Teasdale M. S., Bird C. H., and Bird P. (1994) Internalization of the anticoagulant thrombomodulin is constitutive and does not require a signal in the cytoplasmic domain. Immunol. Cell Biol. 72, 480-488.
37. 2-macroglobulin and interleukin 6 in Alzheimer's disease. Brain Res. 777, 223-227.
38. Vaughan P. J., Su J. H., Cotman C. W., and Cunningham D. D. (1994) Protease nexin-1, a potent thrombin inhibitor, is reduced around cerebral blood vessels in Alzheimer's disease. Brain Res. 668, 160-170.
39. Wagner S. L., Geddes J. W., Cotman C. W., Lau A. L., Gurwitz D., Isackson P. J., and Cunningham D. D. (1989) Protease nexin-1, an antithrombin with neurite outgrowth activity is reduced in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 86, 8284-8288.
40. Wavrant-DeVrieze F., Perez-Tur J., Lambert J. C., Frigard B., Pasquier F., Delacourte A., Amouyel P., Hardy J., and Chartier-Harlin M. C. (1997) Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci. Lett. 227, 68-70.
41. White C. E., Hunter M. J., Meininger D. P., White L. R., and Komives E. A. (1995) Large scale expression, purification and characterization of the smallest active fragment of thrombomodulin: the roles of the sixth domain and of methionine-388. Protein Eng. 8, 1177-1187.
42. Ye J., Esmon C. T., and Johnson A. E. (1993) The chondroitin sulfate moiety of thrombomodulin binds a second molecule of thrombin. J. Biol. Chem. 268, 2373-2379.
43. Zoubine M. N., Ma J. Y., Smirnova I. V., Citron B. A., and Festoff B. W. (1996) A molecular mechanism for synapse elimination: novel inhibition of locally generated thrombin delays synapse loss in neonatal mouse. Dev. Biol. 179, 447-457.